Comparing Touch-Limited and Free-Play 4v4 Small-Sided Games (SSGs)
NCT07395765, Not applicable, Completed, Aksaray University Training and Research Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Comparing Touch-Limited and Free-Play 4v4 Small-Sided Games (SSGs) | ClinicalTrials.gov |
| NCT number | NCT07395765 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 32 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Aksaray University Training and Research Hospital | ClinicalTrials.gov |
| Conditions | BDNF, Small Side Game, Football Players | ClinicalTrials.gov |
| Interventions | SSGf, SSGr | ClinicalTrials.gov |
| First posted | 2026-02-09 | ClinicalTrials.gov |
| Last updated | 2026-02-10 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | BDNF | • Baseline, Immediately After Exercise (Day 1) | BDNF levels were measured using a Sunred Brand Enzyme-Linked İmmunosorbent Assay (ELISA) kit from blood samples taken baseline and after exercise, and the results were reported in ng/mL units. | ClinicalTrials.gov |
| Primary | Lactate | • Baseline, Immediately After Exercise (Day 1) | Lactate levels were measured in millimoles per liter (mmol/L) from capillary/venous blood samples taken before and after exercise using a lactate analyzer. | ClinicalTrials.gov |
| Primary | Stroop Test | • Baseline, immediately after exercise (Day 1) | The Stroop Test is a widely used neuropsychological assessment tool to evaluate selective attention, inhibitory control, processing speed, and executive function under cognitive interference. The Congruent condition measures baseline color-naming speed by requiring participants to respond to stimuli in which the color word matches the ink color. Completion time (or reaction time) and errors were recorded. The Incongruent condition measures inhibitory control and interference resolution by requiring participants to name the ink color while ignoring a conflicting color word. Completion time (or reaction time) and errors were recorded. Performance was evaluated using (i) condition-specific completion/reaction times and error counts and (ii) the Stroop interference score, calculated as the difference between conditions (Incongruent - Congruent) for time (and/or errors). Lower interference values reflect better inhibitory control and interference resolution, whereas higher va | ClinicalTrials.gov |
| Primary | Rating Scale Mental Effort | • Immediately After Exercise (Day 1) | RSME (Rating Scale Mental Effort) is a single-item measure scored on a 0-150 continuum. Immediately after each session, participants indicate their perceived mental effort by marking a 150-mm visual analogue line anchored with verbal descriptors; the distance from the origin is measured in millimeters and recorded as the RSME score (0-150). Higher scores reflect greater perceived mental effort (i.e., a higher cognitive/mental demand imposed by the session). | ClinicalTrials.gov |
| Primary | Feeling Scale | • Baseline, Immediately After Exercise (Day 1), | The Feeling Scale (FS) is a single-item measure used to assess affective valence during exercise and is scored on an 11-point scale ranging from -5 to +5. Participants select the value that best reflects how they feel at a given time point (e.g., during or immediately after exercise), where -5 indicates "very bad," 0 represents a neutral feeling, and +5 indicates "very good." Higher scores denote more positive affective responses, whereas lower scores reflect more negative affective states. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 42632905 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)